HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

DL Nielsen, M Andersson, C Kamby - Cancer treatment reviews, 2009 - Elsevier
There is strong clinical evidence that trastuzumab, a monoclonal antibody targeting the
human epidermal growth factor receptor (HER) two tyrosine kinase receptor, is an important …
被引用次数：198 相关文章

HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

DL Nielsen, M Andersson… - Cancer treatment …, 2009 - pubmed.ncbi.nlm.nih.gov
There is strong clinical evidence that trastuzumab, a monoclonal antibody targeting the
human epidermal growth factor receptor (HER) two tyrosine kinase receptor, is an important …

HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

DL Nielsen, M Andersson… - Cancer Treatment …, 2009 - cancertreatmentreviews.com
There is strong clinical evidence that trastuzumab, a monoclonal antibody targeting the
human epidermal growth factor receptor (HER) two tyrosine kinase receptor, is an important …

[引用][C] HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

Cancer Treatment Reviews, 2008 - healthyaging.ku.dk
HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase
inhibitors - Staff Topic navigation Content Footer links Start Toggle navigation Map Phone …

[引用][C] HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

DL Nielsen, M Andersson, C Kamby - Cancer Treatment Reviews, 2009 - cir.nii.ac.jp
HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase
inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

DL Nielsen, M Andersson, C Kamby - Cancer Treatment Reviews, 2009 - infona.pl
There is strong clinical evidence that trastuzumab, a monoclonal antibody targeting the
human epidermal growth factor receptor (HER) two tyrosine kinase receptor, is an important …

HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors.

DL Nielsen, M Andersson, C Kamby - Cancer Treatment Reviews, 2008 - europepmc.org
There is strong clinical evidence that trastuzumab, a monoclonal antibody targeting the
human epidermal growth factor receptor (HER) two tyrosine kinase receptor, is an important …
[PDF] academia.edu

[PDF][PDF] HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

DL Nielsen, M Andersson, C Kamby - Cancer Treatment Reviews, 2009 - academia.edu
The story of targeted therapy for breast cancer is old and involves oophorectomy,
hypophysectomy, adrenalectomy and endocrine medical therapy throughout the past …